Delubac Corporate & Investment Bank advises on the sale of Biomatlante

12-03-2019

 

Delubac Corporate & Investment Bank supports the Seventure fund and the founders of Biomatlante in the sale of their securities to the British group Advanced Medical Solutions Group (listed on the London Stock Exchange).

Specialised in the design, development and manufacture of surgical dressings and medical care materials, the listed Advanced Medical Solutions Group has acquired Biomatlante SA, the French specialist in biomaterials.

Delubac Corporate & Investment Bank advised and successfully supported the Seventure fund as well as the Biomatlante founding shareholders in the preparation of the sale, the search for potential buyers, up until the final negotiations

« This transaction once again demonstrates the ability of our team to advise managers and shareholders in their M&A operations, both in France and with foreign counterparts,” said Mickaël Hazout, Managing Director, Delubac Corporate & Investment Bank.

>> Click here to read the press release